Physician profile
Patrick E Scanlon
NPI 1669635694
$71,681.30
in general payments reported to CMS, 2019-2025
31 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.19 · 2020: $12.59 · 2021: $767 · 2022: $4,287 · 2023: $9,998 · 2024: $8,667 · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Consulting Fee: $14K · Food and Beverage: $8,136 · Travel and Lodging: $3,417 · Education: $99.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41,274.00 |
| Consulting Fee | $13,629.00 |
| Food and Beverage | $8,136.07 |
| Travel and Lodging | $3,416.99 |
| Education | $99.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $31,793.57 | 2021-2025 | Ofev, Spiriva Respimat |
| Genzyme Corporation | $30,830.84 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $3,610.79 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,608.52 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $570.84 | 2024-2025 | Inspire |
| Mylan Specialty L.P. | $539.34 | 2022-2024 | Yupelri |
| Amgen INC. | $500.92 | 2021-2025 | Tezspire |
| Baxter Healthcare | $330.17 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Synclara Cough System |
| Regeneron Healthcare Solutions, INC. | $325.61 | 2023-2025 | Dupixent |
| Inari Medical, INC. | $179.10 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Grifols USA, LLC | $173.63 | 2021-2023 | Xembify, Prolastin-C Liquid |
| Viatris Specialty LLC | $163.94 | 2025 | Yupelri |
| Philips North America LLC | $122.77 | 2024 | (Ak6) Vest Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $119.21 | 2022-2024 | Cuvitru |
| Harmony Biosciences LLC | $105.61 | 2022-2023 | Wakix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $102.16 | 2024-2025 | Opsumit |
| Ethicon INC. | $100.86 | 2021-2022 | |
| United Therapeutics Corporation | $96.23 | 2023-2024 | Tyvaso |
| Sanofi-Aventis U.S. LLC | $59.80 | 2025 | |
| Electromed, INC. | $54.06 | 2021-2024 | Smartvest |
| Novartis Pharmaceuticals Corporation | $41.64 | 2023 | |
| Abiomed | $38.87 | 2019 | |
| Insmed, INC. | $36.25 | 2025 | Brinsupri, Arikayce |
| Axsome Therapeutics, INC. | $32.23 | 2023 | Sunosi |
| Pfizer INC. | $30.94 | 2023 | |
| Verona Pharma, INC. | $24.61 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $22.00 | 2021 | |
| Ekos Corporation | $20.32 | 2019 | |
| Pulmonx Corporation | $19.08 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| 3b Medical, INC. | $14.80 | 2024 | Luna |
| Merck Sharp & Dohme LLC | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Scanlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.